Section I Experimental.- 1 Introduction to therapy with azapropazone.- 2 The chemical classification of azapropazone.- 3 Survey of toxicological investigations of azapropazone.- 4 The mode of action of azapropazone in relation to its therapeutic actions in rheumatic conditions and its major side-effects.- 5 Pharmacokinetic properties of azapropazone in comparison to other NSAIDs.- 6 The pharmacokinetics of azapropazone.- 7 Mathematical model for assessing risk of gastrointestinal reactions to NSAIDs.- 8 Reduction of irreversible injury in animal models of myocardial ischaemia by treatment with azapropazone.- 9 Dual inhibitory effects of azapropazone on both neutrophil migration and function: relation to cardiovascular function.- 10 Aspects of clinical pharmacology and bioavailability of azapropazone.- 11 Immunochemical studies on azapropazone.- Section II Therapeutic Actions.- 12 Untersuchungen zur Arthrose [Studies in osteoarthritis].- 13 Studies on gout and urate elimination by azapropazone.- 14 Die Analgetische Wirksamkeit von Azapropazon [Analgesic effects of azapropazone].- 15 UEberblick uber die Anwendung von Azapropazon nach operativen Eingriffen und bei traumatisierten Patienten [Review of application of azapropazone in post-operative and traumatic conditions].- 16 Clinical trial methodology in rheumatoid arthritis: azapropazone studies.- 17 Comparative effects of azapropazone on the progression of joint pathology on osteoarthritis.- 18 Serious gastrointestinal reactions to azapropazone: an estimate of the risk.- 19 Tolerance of azapropazone: allergic and pseudo-allergic reactions and comparison with other NSAIDs.- 20 Haematological reactions.- 21 Epilogue, with some thoughts for research on azapropazone.
موضوع (اسم عام یاعبارت اسمی عام)
موضوع مستند نشده
Internal medicine.
موضوع مستند نشده
Medicine.
موضوع مستند نشده
Toxicology.
رده بندی کنگره
شماره رده
RM666
.
A93
نشانه اثر
E358
1990
نام شخص به منزله سر شناسه - (مسئولیت معنوی درجه اول )